Search Results - Zhong, Z.
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label,... by Wu, Y-L, Zhou, C.., Liam, Chong-Kin, Wu, G., Liu, X., Zhong, Z., Lu, S., Cheng, Y., How, Soon Hin, ., et al.
Published 2015Get full text
Get full text
Get full text
-
10
-
11